Genentech, Inc. donated between $100K and $500K to Alzheimer's Foundation of America in 2018
Jun 01, 2020
Donations and Philanthropy
TO PROVIDE OPTIMAL CARE AND SERVICES TO INDIVIDUALS CONFRONTING DEMENTIA.
In The News
Sep 26, 2020 - RelSci
Farlong Pharmaceutical Donates a Portion of Sales Throughout the Month of September to The Alzheimer's Foundation of America; To spread awareness about World Alzheimer's Month, Farlong is donating 10% of sales from Lifeflower® Breviscapine throughout Sept
Sep 14, 2020 - PR Newswire
Sep 12, 2020 - Targeted News Service
Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
In The News
Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19
Nov 23, 2020 - TechCrunch
Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person; - Xofluza is the first single-dose influenza medicine approved to prevent influenza for those who have had contact with an infected pers
Nov 23, 2020 - Business Wire